Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer

Cisplatin is used to treat multiple types of solid tumor, including gastric cancer. Although cisplatin initially exhibits good efficacy, therapeutic failure often occurs owing to the development of chemoresistance. To the best of our knowledge, the underlying mechanism of cisplatin resistance remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Shuquan, Yin, Jie, Bai, Zhigang, Zhang, Zhongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950176/
https://www.ncbi.nlm.nih.gov/pubmed/29805561
http://dx.doi.org/10.3892/ol.2018.8390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950176/
https://www.ncbi.nlm.nih.gov/pubmed/29805561
http://dx.doi.org/10.3892/ol.2018.8390

Ejemplares similares